About imiquimod
Topical immune response modifier
Used for
- External genital and perianal warts
- Actinic keratosis on the face or scalp
- Superficial basal cell skin cancer
Usual adult dose
Warts: apply three times weekly for up to 16 weeks. Actinic keratosis: twice weekly for 16 weeks. Superficial basal cell cancer: five times weekly for 6 weeks.
Common side effects
- Redness, swelling, itching, burning, or pain at application site
- Flaking, scabbing, or skin sores
- Headache
- Flu-like symptoms
Important warnings
- Skin reactions can be severe; treatment may need interruption.
- Avoid eyes, lips, nostrils, and broken skin; wash hands after use.
- Not for internal genital or anal warts, or invasive skin cancer.
- Sun exposure can worsen reactions; use protective clothing and sunscreen.
Pregnancy
Human pregnancy data are limited; use only when clearly needed after medical assessment.
Breastfeeding
It is unknown whether topical imiquimod passes into breast milk; avoid infant contact with treated skin.
Interactions
- No major interactions are established with topical imiquimod.
- Other skin treatments may increase local irritation.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.